Nothing Special   »   [go: up one dir, main page]

Grbic et al., 2011 - Google Patents

In vitro–in vivo correlation for gliclazide immediate-release tablets based on mechanistic absorption simulation

Grbic et al., 2011

View HTML
Document ID
2024452750523782662
Author
Grbic S
Parojcic J
Ibric S
Djuric Z
Publication year
Publication venue
Aaps Pharmscitech

External Links

Snippet

The aim of this study was to develop a drug-specific absorption model for gliclazide (GLK) using mechanistic gastrointestinal simulation technology (GIST) implemented in GastroPlus TM software package. A range of experimentally determined, in silico predicted or literature …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/3456—Computer-assisted prescription or delivery of medication, e.g. prescription filling or compliance checking
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/70—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/20—Handling natural language data
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/15—Medicinal preparations; Physical properties thereof, e.g. dissolubility

Similar Documents

Publication Publication Date Title
Grbic et al. In vitro–in vivo correlation for gliclazide immediate-release tablets based on mechanistic absorption simulation
Dahan et al. Prediction of solubility and permeability class membership: provisional BCS classification of the world’s top oral drugs
O'Dwyer et al. In vitro methods to assess drug precipitation in the fasted small intestine–a PEARRL review
Chavda et al. Biopharmaceutics classification system
Anand et al. Dissolution testing for generic drugs: an FDA perspective
Stillhart et al. PBPK absorption modeling: establishing the in vitro–in vivo link—industry perspective
García-Arieta et al. Bioequivalence requirements in the European Union: critical discussion
Pathak et al. Biopharmaceutic IVIVE—mechanistic modeling of single-and two-phase in vitro experiments to obtain drug-specific parameters for incorporation into PBPK models
Fagerberg et al. Intestinal solubility and absorption of poorly water soluble compounds: predictions, challenges and solutions
Wu et al. Physiologically based pharmacokinetics modeling in biopharmaceutics: case studies for establishing the bioequivalence safe space for innovator and generic drugs
Li et al. Justification of biowaiver and dissolution rate specifications for piroxicam immediate release products based on physiologically based pharmacokinetic modeling: an in-depth analysis
Hofsäss et al. The discriminatory power of the BCS-based biowaiver: a retrospective with focus on essential medicines
Cardot et al. Implementing the biopharmaceutics classification system in drug development: reconciling similarities, differences, and shared challenges in the EMA and US-FDA-recommended approaches
Lionberger et al. Use of partial AUC to demonstrate bioequivalence of zolpidem tartrate extended release formulations
Hansmann et al. Forecasting oral absorption across biopharmaceutics classification system classes with physiologically based pharmacokinetic models
Yasuji et al. The effect of food on the oral bioavailability of drugs: a review of current developments and pharmaceutical technologies for pharmacokinetic control
Jede et al. Improved prediction of in vivo supersaturation and precipitation of poorly soluble weakly basic drugs using a biorelevant bicarbonate buffer in a gastrointestinal transfer model
Jereb et al. In vitro–in vivo relationship and bioequivalence prediction for modified-release capsules based on a PBPK absorption model
Xia et al. Utility of physiologically based modeling and preclinical in vitro/in vivo data to mitigate positive food effect in a BCS class 2 compound
Abebe et al. In vitro comparative quality assessment of different brands of furosemide tablets marketed in Northwest Ethiopia
Kiyota et al. Importance of gastric secretion and the rapid gastric emptying of ingested water along the lesser curvature (“Magenstrasse”) in predicting the in vivo performance of liquid oral dosage forms in the fed state using a modeling and simulation
Hens et al. Dissolution challenges associated with the surface pH of drug particles: integration into mechanistic oral absorption modeling
Mahayni et al. Evaluation of “external” predictability of an in vitro–in vivo correlation for an extended‐release formulation containing metoprolol tartrate
Loisios-Konstantinidis et al. Physiologically based pharmacokinetic/pharmacodynamic modeling to support waivers of in vivo clinical studies: current status, challenges, and opportunities
Pavurala et al. A mechanistic approach for modeling oral drug delivery